Compare RVMD & VST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RVMD | VST |
|---|---|---|
| Founded | 2014 | 1882 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.3B | 47.0B |
| IPO Year | 2020 | 2016 |
| Metric | RVMD | VST |
|---|---|---|
| Price | $193.42 | $151.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 24 | 21 |
| Target Price | ★ $259.14 | $210.25 |
| AVG Volume (30 Days) | 2.2M | ★ 5.5M |
| Earning Date | 11-04-2026 | 11-06-2026 |
| Dividend Yield | N/A | ★ 0.57% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.64 |
| Revenue | N/A | ★ $17,738,000,000.00 |
| Revenue This Year | N/A | $26.76 |
| Revenue Next Year | $564.95 | $7.35 |
| P/E Ratio | ★ N/A | $44.60 |
| Revenue Growth | N/A | ★ 2.98 |
| 52 Week Low | $49.05 | $132.66 |
| 52 Week High | $224.31 | $217.10 |
| Indicator | RVMD | VST |
|---|---|---|
| Relative Strength Index (RSI) | 44.06 | 52.17 |
| Support Level | $188.18 | $151.09 |
| Resistance Level | $194.19 | $154.02 |
| Average True Range (ATR) | 8.63 | 7.33 |
| MACD | -1.27 | 1.49 |
| Stochastic Oscillator | 41.68 | 47.47 |
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
Vistra Corp. is one of the largest power producers and retail energy providers in the US. It owns 44 gigawatts of generation capacity, including natural gas (27 GW), nuclear (6.5 GW), coal (8.7 GW), and solar and battery storage (1.3 GW). The Cogentrix acquisition will add 5.5 GW of gas generation. Vistra's retail electricity business serves 5 million customers in 20 states, including almost a third of all Texas electricity consumers. Vistra emerged from the Energy Future Holdings bankruptcy as a stand-alone entity in 2016.